728 related articles for article (PubMed ID: 24633668)
41. [Radiation therapy for non-small cell lung cancer with postoperative intrathoracic recurrence].
Kono K; Murakami M; Sasaki R; Okamoto Y; Yodenn E; Kobayashi K; Kubo T; Sai H; Maetani Y; Kuroda Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jan; 58(1):18-24. PubMed ID: 9493429
[TBL] [Abstract][Full Text] [Related]
42. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ
Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543
[TBL] [Abstract][Full Text] [Related]
43. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
45. Clinical Outcomes in Early-stage NSCLC Treated with Stereotactic Body Radiotherapy Versus Surgical Resection.
Kastelijn EA; El Sharouni SY; Hofman FN; Van Putte BP; Monninkhof EM; Van Vulpen M; Schramel FM
Anticancer Res; 2015 Oct; 35(10):5607-14. PubMed ID: 26408733
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer.
Song IH; Yeom SW; Heo S; Choi WS; Yang HC; Jheon S; Kim K; Cho S
Eur J Cardiothorac Surg; 2014 Feb; 45(2):262-7. PubMed ID: 23811122
[TBL] [Abstract][Full Text] [Related]
47. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
48. Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study.
Dong S; Zhao N; Deng W; Sun HW; Niu FY; Yang JJ; Zhong WZ; Li F; Yan HH; Xu CR; Zhang QY; Yang XN; Liao RQ; Nie Q; Wu YL
World J Surg Oncol; 2017 Jan; 15(1):12. PubMed ID: 28069039
[TBL] [Abstract][Full Text] [Related]
49. Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.
Matsuo Y; Shibuya K; Nagata Y; Takayama K; Norihisa Y; Mizowaki T; Narabayashi M; Sakanaka K; Hiraoka M
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1104-11. PubMed ID: 20472343
[TBL] [Abstract][Full Text] [Related]
50. High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resection.
Chang PM; Yeh YC; Chen TC; Wu YC; Lu PJ; Cheng HC; Lu HJ; Chen MH; Chou TY; Huang CY
Ann Surg Oncol; 2013 Oct; 20(11):3648-54. PubMed ID: 23775407
[TBL] [Abstract][Full Text] [Related]
51. EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-tyrosine kinase inhibitors in recurred cases.
Lee JS; Kim HR; Lee CY; Shin M; Shim HS
Ann Surg Oncol; 2013 Sep; 20(9):3015-22. PubMed ID: 23525704
[TBL] [Abstract][Full Text] [Related]
52. Preliminary report of late recurrences, at 5 years or more, after stereotactic body radiation therapy for non-small cell lung cancer.
Matsuo Y; Shibuya K; Nagata Y; Norihisa Y; Narabayashi M; Sakanaka K; Ueki N; Mizowaki T; Hiraoka M
J Thorac Oncol; 2012 Feb; 7(2):453-6. PubMed ID: 22252562
[TBL] [Abstract][Full Text] [Related]
53. [Present status and problems of surgical treatment of non-small cell lung cancer].
Fujisawa T; Yamaguchi Y; Shiba M; Baba M; Yusa T; Yamakawa H; Kimura H; Iwai N; Nomoto Y; Yamaguchi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):210-5. PubMed ID: 2162440
[TBL] [Abstract][Full Text] [Related]
54. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
[TBL] [Abstract][Full Text] [Related]
55. The Frequency and Prognostic Impact of Pathological Microscopic Vascular Invasion According to Tumor Size in Non-Small Cell Lung Cancer.
Shimada Y; Saji H; Kato Y; Kudo Y; Maeda J; Yoshida K; Hagiwara M; Matsubayashi J; Kakihana M; Kajiwara N; Ohira T; Ikeda N
Chest; 2016 Mar; 149(3):775-85. PubMed ID: 26379115
[TBL] [Abstract][Full Text] [Related]
56. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
[TBL] [Abstract][Full Text] [Related]
57. Results of T4 surgical cases in the Japanese Lung Cancer Registry Study: should mediastinal fat tissue invasion really be included in the T4 category?
Watanabe S; Asamura H; Miyaoka E; Okumura M; Yoshino I; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Yokoi K;
J Thorac Oncol; 2013 Jun; 8(6):759-65. PubMed ID: 23608818
[TBL] [Abstract][Full Text] [Related]
58. Impact of extratumoral lymphatic permeation on postoperative survival of non-small-cell lung cancer patients.
Matsumura Y; Hishida T; Shimada Y; Ishii G; Aokage K; Yoshida J; Nagai K
J Thorac Oncol; 2014 Mar; 9(3):337-44. PubMed ID: 24496002
[TBL] [Abstract][Full Text] [Related]
59. Incidence of local recurrence and second primary tumors in resected stage I lung cancer.
Martini N; Bains MS; Burt ME; Zakowski MF; McCormack P; Rusch VW; Ginsberg RJ
J Thorac Cardiovasc Surg; 1995 Jan; 109(1):120-9. PubMed ID: 7815787
[TBL] [Abstract][Full Text] [Related]
60. Survival of M1a Non-Small Cell Lung Cancer Treated Surgically: A Retrospective Single-Center Study.
Liu T; Liu H; Wang G; Zhang C; Liu B
Thorac Cardiovasc Surg; 2015 Oct; 63(7):577-82. PubMed ID: 25893920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]